Coronavirus has already disturbed several lives, the whole world is

fighting with this deadly virus and now another news linked with this virus
is coming up. Medical experts at Delhi's Sir Ganga Ram Hospital found
multiple cases of Mucormycosis, a rare fungal infection in the recovering
coronavirus patients. They said that nearly half of them have lost their
eyesight.

An advisory has also been issued by the Gujarat health department after
seeing that some patients of the COVID-19 within the state were found
infected with a rare fungal infection known as mucormycosis which has a
“mortality rate of nearly 50 percent”. It is also mentioned that
mucormycosis infects people with a weak immune system and those with
other existing illnesses. 

As per Medical experts, this affliction is rare but not new though what is
new is the impact of COVID-19 behind triggering this deadly infection. 

Now, let us study Mucormycosis

According to the CDC, mucormycosis sometimes known
as zygomycosis is a serious but rare fungal infection that is caused due
to a group of molds called mucormycetes. These fungi live throughout the
environment mainly in soil and in decaying matter including leaves,
compost piles, or rotten wood.
The disease mainly infects people who have some sort of health problems
or take medicines that lower the ability of the body to fight germs and
sickness. Mostly, it affects the sinuses or the lungs after inhaling fungal
spores from the air, or the skin after the fungus enters the skin through
the cut, burn, or any other type of skin injury. Therefore, it can occur in
nearly any part of the body.

Mucormycosis: Symptoms
Mucormycosis symptoms depend upon where the fungus is growing in the
body. Some common symptoms are as follows:

- Swelling in one side of the face

- Headache

- Nasal or Sinus congestion

- Fever

- Cough

- Chest Pain

- Shortness of breath
- Black lesions on nasal bridge or upper inside mouth

- Abdominal pain, etc.

Note: Symptoms like fever, cough, and shortness of breath are also

prevalent in COVID-19 patients.